Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT01471353
Title Sorafenib Plus Capecitabine (SorCape) in Previously Treated Metastatic Colorectal Cancer
Recruitment Completed
Gender both
Phase Phase II
Variant Requirements No
Sponsors University of Florida

colon adenocarcinoma

rectum adenocarcinoma

colorectal adenocarcinoma


Capecitabine + Sorafenib

Age Groups: adult
Covered Countries USA

No variant requirements are available.